Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-24 @ 7:02 PM
NCT ID:
NCT04687657
Eligibility Criteria:
Inclusion Criteria:
* Age ≥60 years
* Patients with primary AML diagnosed in accordance with the "Adult Acute Myeloid Leukemia (Non-Acute Promyelocytic Leukemia) Chinese Diagnosis and Treatment Guidelines (2017 Edition)", who achieved CR after induction chemotherapy
* Normal heart function , Ejection fraction ≥ 50%
* Normal liver function with ALT and AST ≤ 2.5 times the upper limit of normal value, bilirubin ≤ 2 times the upper limit of normal value
* Normal kidney function with blood creatinine ≤ 3.0 mg/dL (≤ 260 µmol/L)
* Voluntarily signed an informed consent.
Exclusion Criteria:
* Combined with severe infection
* Combined with other malignant tumors
* Other patients deemed unsuitable to be tested by the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT04687657
Study Brief:
Protocol Section:
NCT04687657